(1)
Akimov, A.; Cherniavskyi , V. Comparative Effects of Liraglutide and Dapagliflozin on Lipid Profile and Cardiovascular Risk in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes: A 6-Month Randomized Study. USMYJ 2025, 158, 17-26.